An update: Cancer-associated anorexia as a treatment target

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 4, Issue 3, 2001, Pages 179-182

  Jatoi, Aminah ^a   Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROHEPTADINE; DEXAMETHASONE; MEGESTROL ACETATE;

ANIMAL; ANOREXIA; APPETITE; CLINICAL TRIAL; DRUG EFFECT; EATING; EATING DISORDER; FOOD INTAKE; HUMAN; NEOPLASM; REVIEW; WEIGHT REDUCTION;

ANIMALS; ANOREXIA; APPETITE; APPETITE REGULATION; CLINICAL TRIALS; CYPROHEPTADINE; DEXAMETHASONE; EATING; EATING DISORDERS; HUMANS; MEGESTROL ACETATE; NEOPLASMS; WEIGHT LOSS;

EID: 0035351249     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200105000-00002     Document Type: Review

References (17)

1. Walsh D, Donnelly S, Rybick L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1000 patients. Support Care Cancer 2000; 8:175-179.
2. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000; 342:326-333.
3. Van der Molen B. Relating information needs to the cancer experience. Jenny's story: a cancer narrative. Eur J Cancer Care 2000; 9:41-47.
4. Holden CM. Anorexia in the terminally ill cancer patient: the emotional impact on the patient and the family. Hosp J 1991; 7:73-84.
5. Geels P, Eisenhauer E, Bezjak A, et al. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 2000; 18:2395-2405.
6. Kirkbride P, Bezjak A, Pater J, et al. Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol 2000; 18:1960-1966.
7. Loprinzi CL, Kugler JW, Sloan JA, et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999; 17:3299-3306. This large randomized trial demonstrated that megestrol acetate and dexamethasone are equivalent in their orexigenic effects at the doses prescribed and that the androgen fluoxymesterone has relatively little palliative effect. This study provides the rationale, based on the toxicity profile of each agent, for treating patients with a limited life expectancy with dexamethasone and with a slightly longer life expectancy with megestrol acetate.
8. Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990; 82:1127-1132.
9. Eisen T, Boshoff C, Mak I, et al. Continuous low dose thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. Br J Cancer 2000; 82:812-817.
10. Agteresch HJ, Dagnalie PC, der Gaast A, et al. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small cell lung cancer. J Natl Cancer Inst 2000; 92:321-328. This clinical trial tested a novel agent, ATP, in the treatment of cancer-associated anorexia and weight loss in patients with advanced non-small cell lung cancer. The favorable results in this study suggest that ATP deserves further testing.
11. Edelman MJ, Gandara DR, Meyers FJ, et al. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome. Cancer 1999; 86:684-688.
12. Bruera E, Belzile M, Neumann C, et al. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 2000; 19:427-435.
13. Darnton SJ, Zgainski B, Grenier I, et al. The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Dis Esophagus 1999; 12:283-288.
14. Kawamura I, Morishita R, Tomita N, et al. Intratumoral injection of oligonucleotides to the NFkappaB binding site inhibits cachexia in a mouse tumor model. Gene Ther 1999; 6:91-97. By testing a decoy of oligonucleotides that block NF-κB transactivation of gene expression of cytokines, this study introduces a novel approach to the palliation of cancer-associated anorexia and weight loss.
15. r TNF receptor construct, this study introduces another novel approach to the palliation of cancer-associated anorexia.
16. Cahlin C, Korner A, Axelson H, et al. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-γ, and tumor necrosis factor α evaluated in gene knockout, tumor-bearing mice on C57 B1 backgound and eicosanoid-dependent cachexia. Cancer Res 2000; 60:5488-5493.
17. McCarthy DO. Inhibitors of prostaglandin synthesis do not improve food intake or body weight of tumor-bearing rats. Res Nursing Health 1999; 22:380-387.